Search Results 2071-2080 of 16801 for CLL

  1. Health & Wellness - 2013 Archives - Page 6 of 52 - Mayo Clinic News Network

    https://www.youtube.com/watch?v=oGftj-R2drI My Family's Battle with Rare Kidney Disease Gives Hope to Others Seeking a Lifesaving Transplant By: Jane ...

  2. Cholangiocarcinoma (bile duct cancer) - Doctors and departments - Mayo Clinic

    Learn about symptoms, risk factors, diagnosis and treatment, including transplant, for this rare cancer that affects the bile ducts of older adults.

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  4. PULSE CHECK: HEALTH OPINIONS & BEHAVIORS IN AMERICA

    As election season heats up, so do our conversations; health is always a lively topic. The second Mayo Clinic National Health Check-Up explores health.

  5. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.

  6. Osteoarthritis - Doctors and departments - Mayo Clinic

    This most common form of arthritis mainly affects joints in your hands, knees, hips and spine. There's no cure, but symptoms can be managed.

  7. Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) - Mayo Clinic

    This double-blind randomized, parallel group study will evaluate the efficacy and safety of lenalidomide (Revlimid, CC-5013) in combination with rituximab ( ...

  8. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Spinal cord tumors can cause serious problems such as pain and paralysis. Find out about diagnosis and treatment.

  9. Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia - Mayo Clinic

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

  10. A Study to Evaluate Non-Operative Management and Early Response Assessment in Rectal Cancer - Mayo Clinic

    The purpose of this study is to determine if the complete clinical response rate of patients with Stage I-IIIB (cT1-3, N0-1, M0) rectal cancer being treated ...